This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $4,829.60 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024, with a completion date of November 4, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.
Generated 1/31/25, 9:02 AM